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Abstract
Food allergies, including kiwi fruit allergy, have been the subject of extensive research in the last
few years. The aim of this study was to examine a possible relationship between the
developmental stage of kiwi fruit and its allergenic potency. The protein and allergen patterns
of kiwi fruit extracts in September, October, November and December fruit in the period from
2000/2002 were analysed. One of the factors that may contribute to the difficulties in
proposing well-defined and standardized fruit extracts should also be the time of fruit
harvesting. In this particular case, when the kiwi fruit was edible throughout November and
December, we showed discrepancies in allergen content and potencies both in qualitative and
quantitative terms. Two major allergens of kiwi fruit, Act c 1 and Act c 2, mainly accounted for
the highest allergenic potential of November kiwi extract in vivo and in vitro. Not only the
content of major allergens, but also the ratio of different proteins and even isoforms of the same
allergen (Act c 2) change with fruit ripening. These findings should be taken into account
during preparation of extracts for allergy diagnosis.
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Introduction
Food allergy is an important health problem nowadays. Clinical reactions to food,
including cutaneous, gastrointestinal or respiratory disorders or systemic anaphylactic
reactions (Sampson 1999) are demonstrated by 8% of children and 2% of adults
(Helm & Burks 2000). It is likely that both the incidence and prevalence of food
allergies are increasing in line with other forms of allergic diseases (Kimber &
Dearman 2001). Food allergy can develop as an isolated reaction to food (fruit, fish,
milk) or a secondary reaction after sensitization to pollen (oral-allergy syndrome,
OAS) or latex (latex-fruit syndrome) when food allergens cross-react with allergens
present in pollen or latex. It is generally believed that food allergens are proteins
resistant to digestion because only intact proteins (or their larger fragments) are
required for processing by antigen-presenting cells located in gut mucosa. Although
stability under digestion may not be the defining characteristic of food allergens, it is
widely accepted that resistance to digestion would increase the probability of
stimulating allergic reactions presumably by retaining protein integrity (Fu 2002).
Thus, digestibility tests have been widely accepted as an appropriate method for
evaluating the potential allergenicity of newly-introduced proteins in genetically
modified plants (Metcalfe et al. 1996, Fu et al. 2002).
Kiwi fruit is very popular throughout the world because of its taste and high vitamin
C content. The kiwi fruit harvest season is in late autumn in the Mediterranean area.
September and October fruits are not edible because they are hard, sour and lacking
aroma. The fruit is fully ripened in November and December.
Accompanying the growing popularity of kiwi fruit in the regular diet, there has
been an increasing number of reports of adverse and allergic reactions to kiwi (Garcia
et al. 1989, Pastorello et al. 1996, Pastorello et al. 1998, Rudescho et al. 1998,
Gavrovic-Jankulovic et al. 2002b, Bublin et al. 2004), which is often pollen associated.
According to earlier studies, at least 12 IgE binding proteins (allergens) could be
detected in kiwi extract with molecular weights ranging from 64/12 kDa (Pastorello et
al. 1996). Two major allergens of kiwi fruit have been isolated and characterized. Act c
1, a protein of molecular mass about 30 kDa, commonly known as actinidin
(Pastorello et al. 1998) is a cysteine protease related to papain (Varughese et al.
1992). Act c 2 is a thaumatin-like protein, the plant defense protein with proven
antifungal activity (Gavrovic-Jankulovic et al. 2002b, Wang et al. 2002) that, in kiwi
extract, exists in two isoforms differing slightly in pI value (9.4 and 9.5) with
molecular mass of about 24 kDa (Gavrovic-Jankulovic et al. 2002b).
Allergenicity of fruit during development depends on the expression of IgE-binding
proteins. Vieths et al. (1994) demonstrated that the severity of symptoms in patients
allergic to apples was highly correlated with the appearance of 18 kDa apple allergen
during storage and suggested that this was caused by ripening. Additionally, Paschke
et al. (2001) have correlated the number and intensity of bands in immunoblots with
ripening stages of mango fruit and observed no difference caused by ripening.
Allergenic extracts, made by different manufacturers, for the use in diagnosis and
therapy of allergic diseases usually show variations in allergenic potency. Especially
allergen extracts from fruits, vegetables and other plant foods often lack sufficient
biological activity due to the presence of proteolytic enzymes, carbohydrates, and
phenol components (Vieths et al. 2001). That is the consequence of applying different
extraction methods and source materials. In the last few years several in vivo (such as
skin prick testing, food challenge, etc.) and in vitro (measurement of the content of the
118 M. Gavrovic-Jankulovic et al.
major allergen) methods for standardization of allergenic extracts have been proposed
(Yunginger 1991, Esch 1997, Duffort et al. 2002).
The purpose of this study was to examine a possible relationship between the
developmental stage (from September to December) of kiwi fruit and its allergenic
potency. We monitored the protein and allergen content during development,
digestibility of allergen samples in simulated gastric fluid and allergenic potential in
vivo by skin prick testing (SPT). In the purpose of standardization, we correlated
three different methods for the quantification of the major allergen Act c 1.
Materials and methods
Fruit collection and protein extract preparation
Kiwi fruits (Actinidia deliciosa , Monti cultivar) were collected monthly from
September to December in the period from 2000 to 2002, from the same tree in
Bar, Montenegro. The fruits were stored at /208C without specific treatment until
use. The extracts were made according to previously published protocol (Gavrovic-
Jankulovic et al. 2002b). Briefly, the fruits were homogenized 1: 2 (w/v) in 100 mM
sodium bicarbonate buffer, pH 9.3 containing 2% polyvinylpoly-pyrrolidone (PVPP)
and 0.02% NaN3 in a blender for 1 min. After extraction and centrifugation,
ammonium sulfate was dissolved in the supernatants to achieve 90% saturation. After
overnight standing at 48C the solutions were centrifuged for 20 min at 10000/g. The
obtained pellets were dissolved in a minimal volume of a starting buffer and dialyzed
extensively against the same buffer. Protein concentration in the extract was
determined by the Bradford assay (Bradford 1976).
Sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE). SDS-PAGE was
performed on 4% stacking gel and 10% or 12% resolving gel according to the method
of Laemmli (Laemmli 1970) under reducing and non-reducing conditions. Twelve
micrograms of proteins per lane were applied on the gel for Coomassie Brilliant Blue
(CBB) staining or semidry transfer (0.8mAcm2) to a nitrocellulose membrane
(Serva) for further examination. The content of major allergen Act c 1 in kiwi fruit
extracts was determined by densitometric analysis after SDS-PAGE under reducing
conditions.
Two-dimensional polyacrylamide gel electrophoresis. Two-dimensional PAGE isoelectric
focusing was performed in a model 2117 Multiphor cell (LKB Pharmacia), according
to the manufacturer’s instructions. The proteins (35 mg per lane) were applied to
isoelectric focusing gel and further separated by SDS-PAGE under the conditions
previously described (Gavrovic-Jankulovic et al. 2000).
Immunoblotting. The separated proteins on the gel were transferred onto a nitrocellu-
lose membrane, as described by Towbin et al. (1979). The quality of the transfer was
checked by staining the nitrocellulose with 0.1% Ponceau S in 5% acetic acid. The
nitrocellulose membranes were blocked with 1% bovine serum albumine (BSA) in
Tris-buffered saline (TBS) containing 0.05% Tween 20, pH 7.8 for 1 hour at
room temperature. After blocking, the membranes were incubated with the allergic
patients’ serum diluted 1: 5 in 0.1% BSA in TBS containing 0.05% Tween 20,
pH 7.8 for 5 hours. The blots were washed extensively with TBS containing 0.05%
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Tween 20, pH 7.8 and incubated for 2h with 1: 1000 diluted monoclonal anti-human
IgE antibody labeled with alkaline phosphatase (Abcam Ltd., Cambridge Science
Park) and, after washing, were visualized using nitro blue tetrazolium and 5-bromo-
4-chloro-3-indolyl phosphate (Sigma Chemical Co., St Louis, MO, USA) as
substrates as described (Gavrovic-Jankulovic et al. 2002a). A serum pool of non-
allergic persons was used as the negative control.
Digestion with simulated gastric fluid. The digestibility of kiwi proteins in simulated
gastric fluid (SGF) was examined according to the method of Yagami et al. (2000).
Briefly, 140 mg of kiwi extract proteins was dissolved in 40 mL of prewarmed SGF (US
Pharmacopoeia) containing 0.32% w/v of pepsin A (Sigma Chemical Co.). Digestion
proceeded at 378C with continuous shaking and an aliquot (8 mL) of the digest was
periodically withdrawn (at 8 and 30 minutes). The digestion was stopped with 2.4 mL
0.2 M Na2CO3, and samples were mixed with a sample buffer for SDS-PAGE
analysis.
Determination of proteolytic activity of actinidin. Proteolytic activity of actinidin in
different kiwi fruit samples towards 0.5 mM Na-Benzoyl-DL-Arginine 4-nitroanilide
(Sigma) in 0.1 M potassium phosphate buffer, pH 6.5, containing 1mM EDTA, 13
mM L-cysteine and 5 mM dithiothreitol at RT was evaluated by spectral analysis at
410 nm. Specific proteolytic activity was calculated using excintion coefficient of 4-
nitroaniline and protein concentrations data. Relative proteolytic activity was
calculated as percent of November extract proteolytic activity (set up as 100%).
Effects of the fruit extract pigments were minimized by preparing probes for each
sample without addition of the substrate. Absorbance was read after 1 h of incubation.
A zymogram was run according to Grobe et al. (2002) with some modifications.
Briefly, 12 mg of November kiwi extract proteins previously resolved by isoelec-
trofocusing were applied to 12% resolving gel copolymerized with 0.1% gelatin for
2D-PAGE analysis. After electrophoresis, the gel was incubated in a buffer containing
0.1 M glycine, 10 mM Ca2, 5 mM dithiothreitol and 10 mM cysteine, pH 3.6, for
16 h, followed by staining with CBB.
Antisera production. Antibodies against the December kiwi extract were raised in
rabbits according to Harboe and Ingild (1983). The animals were injected with
0.5 mL of a 1:1 emulsion of ripe kiwi extract (1 mgmL1) in complete Freund’s
adjuvant. Bleeding was performed 50 days after the first immunization and every two
weeks thereafter. The presence of antibodies to kiwi proteins was detected by
immunodiffusion. The serum was partially purified by ammonium sulfate fractiona-
tion (50% saturation).
Rocket immunoelectrophoresis (RIE). The kiwi extract proteins (5.5 mg) were applied to
1% agarose gel containing 13% rabbit antibodies on a glass plate (12/7 cm).
Electrophoresis was carried out in a buffer containing 5 mM barbital, 25 mM Na-
barbital, pH 8.6, for 12 h at 2 V cm1. In order to compare the amount of the major
allergen Act c 1 in different kiwi fruit samples, we applied 2.75 mg Act c 1 isolated
according to Carne and Moore (1978) without derivatization with S-sulphenyl
thiosulphate on the same agarose gel.
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Patient sera. Five sera from patients allergic to kiwi fruit were used in this study (1, 2,
3, 4 and 5). All the patients showed OAS and one of them had severe contact
dermatitis and anaphylaxis when touching the fruit (case No. 4 in Table I).
Skin tests. The extracts for skin prick testing (SPT) were prepared in phosphate-
buffered saline (PBS) (10 mM phosphate buffer, 0.9% NaCl, pH 7.2) 1:1 (w/v),
centrifuged for 5 min at 10000/g, filtered and neutralized with NaHCO3 yielding a
final protein concentration of 0.07 mgmL1. SPT as performed on the volar surface
of the forearm with the kiwi extracts prepared as previously described (Malling 1993).
Histamine (0.010 mgL1) was used as the positive control and saline (0.9%) as the
negative control. The results of SPT were read after 20 min. Wheal diameters were
expressed relative to the histamine response.
Results
Kiwi fruit extracts
Kiwi fruit extracts (gathered in 2000, 2001 and 2002) were compared using SDS-
PAGE, immunoblot and rocket immunoelectrophoresis. The same protein/antigen/
allergen patterns were observed in all three years investigated. The concentration of
proteins in kiwi fruit extracts increased with fruit development. The results presented
here were all obtained using samples from the year 2001.
Protein patterns and actinidin activity in the zymogram. At least 10 protein bands with
molecular weights between 67 and 10 kDa were detected by CBB staining in extracts
of kiwi fruit from September to December. SDS-PAGE patterns under reducing (see
Figure 1a) and non-reducing (Figure 1b) conditions were quite different. The most
noticeable difference was in the mobility of the 24 and 30 kDa proteins in reducing
conditions (most likely a thaumatin like protein and actinidin, respectively) compared
to non-reducing conditions, when they exhibited 20 and 27 kDa molecular weights,
respectively. The protein of 29 kDa was constitutively expressed. We also noticed three
protein bands of 10, 12 and 14 kDa with similar appearance and in similar amounts
from September to December. Several more protein bands of about 42, 56 and 62
kDa were also present in the extracts of fruits from September to December. Protein
bands of 17, 22 and 39 kDa appeared in September and reached the highest intensity











1 RC/ OAS / / // /
2 BA/ OAS /// /// ///// ///
3 RC/OAS /// /// //// ///
4 CD/A // // ///// ////
5 RC/AE /// /// ///// ///
OAS, oral-allergy syndrome; RC, rhinoconjunctivitis; BA, bronchial asthma; AE, angioedema; A, systemic
anaphylaxis; CD, contact dermatitis. The protein concentration in the extracts for the experiment of SPT
has adjusted to 0.07 mgmL1.
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in December. Other protein bands of 26 and 67 kDa appeared in September and
became most abundant in November.
Two-dimensional PAGE (Figure 2) showed fragmentation of the 30 kDa protein
(actinidin), pI 3.6 into a 26 kDa protein with a pI value of 3.2. Both the protein and
Figure 1. SDS PAGE of kiwi fruit extracts.
Lane m, Molecular weight markers; S, September; O, October; N, November and D, December kiwi fruit
extract; a) separation in reducing conditions; b) separation in non-reducing conditions.
Figure 2. Two-dimensional PAGE of kiwi fruit extracts.
Lane m, Molecular weight markers
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protein fragment showed proteolytic activity in zymogram (Figure 3). We observed
two more proteins of 39 and 17 kDa with pI values of 5.0 and 4.8, respectively.
The major kiwi fruit allergen Act c 2 was present in all extracts as a mixture of
isoforms with isoelectric points of 9.4 and 9.5 and a molecular weight of 24 kDa
(Gavrovic-Jankulovic et al. 2002b). Its content increased with fruit development. The
amount of the 26 kDa protein, pI 8.8, was the highest in the November extract. Also, a
protein of 17 kDa with pI 9.0 reached the highest band intensity in the December kiwi
fruit extract.
Human IgE binding. In immunoblots developed with individual sera (1, 2, 3, 4) or pool
of the patients sera (1, 2, 3, and 4) (see Figure 4a) a significant number of IgE binding
proteins were detected. The most intensive bands found in all four extracts, were 30
and 24 kDa proteins (corresponding to actinidin and thaumatin-like protein). An
allergen of 29 kDa was also present in all extracts. Other allergens clearly showed a
dependence on the developmental stage. IgE-binding proteins of 17, 26, 39, 42, 56
and 62 kDa were more abundant in later months. Allergens of 42 and 68 kDa were
present in the October and November samples. The allergen of 22 kDa was most
pronounced in the November sample.
Another immunoblot developed after incubation with serum from patient No. 5
(Figure 4b), showed no difference between the extracts of kiwi fruits in different stages
of development. Each strip had only one band corresponding to a 24 kDa protein.
However, according to the SPT results (case No. 5 in Table I), a quantitative
difference between the extracts tested for the same patient did exist. An explanation
for the phenomenon that in vivo testing appeared much more sensitive than in vitro
Figure 3. Proteolytic activity of actinidin fragments from the November kiwi fruit extract after 2D PAGE.
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techniques, could be that not all of the mainly conformational IgE-binding epitopes
have been renaturated after transfer to the NC membrane for immunoblot analysis, as
demonstrated for some other allergens of different sources (Nilsen et al. 1991).
Quantification of actinidin. The quantity of actinidin in our samples (see Table II) was
measured using three different methods: rocket immunoelectrophoresis, densitometry
and determination of proteolytic activity. Rocket immunoelectrophoresis was run
according to Hudson and Hay (1989). According to all three methods used in this
study, the quantity of Act c 1 was the most pronounced in November kiwi fruit extract
(Table II). The most noticeable difference in Act c 1 content between the November
kiwi fruit extract and the other three kiwi fruit extract was obtained by determination
of proteolytic activity.
Digestibility of kiwi proteins. All kiwi proteins in September, October, November and
December kiwi fruit extracts were decomposed completely within 30 minutes of
exposure to simulated gastric fluid (see Figure 5), but the 24 kDa protein (presumably
Figure 4. Binding patterns of patients’ IgE to kiwi fruit extracts after Western blotting. a) immunoblot with
serum pool; b) immunoblot with serum from patient 2.
S, September; O, October; N, November and D, December kiwi fruit extract.
Table II. Quantity of major allergen Act c 1 determined by three different methods.
Kiwi fruit sample
Method used S# S* O# O* N# N* D# D*
RIE 43.6 81.3 43.6 81.3 53.6 100 43.6 81.3
Densitometry 36.9 93.9 37.6 95.7 39.3 100 35.7 90.8
Relative proteolytic activity of Act c 1D 51.1 65.7 100 70.6
S, September; O, October; N, November; D, December; RIE, Rocket immunoelectrophoresis; #% of total
protein quantity; *% of November actinidin quantity; D% of November actinidin activity.
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a thaumatin-like protein (TLP), Act c 2) appeared to be more resistant to digestion by
gut enzymes in unripe fruit extracts.
Skin prick testing. The results of SPT and patients’ clinical characteristics are shown in
Table I. All patients exhibited the most pronounced reaction to the November kiwi
fruit extract. The intensity of the reaction to November kiwi fruit extract was
approximately twice as strong as the response to the other kiwi fruit extracts
(September, October and December).
Discussion
The aim of this study was to correlate the allergen profile and content in kiwi fruit
during ripening and to answer the question whether the allergenicity and the
digestibility of the fruit depend on its developmental stage or not.
We analysed kiwi fruit extracts from three consecutive years (2000, 2001 and 2002)
by SDS-PAGE, 2D-PAGE, immunoblot and rocket immunoelectrophoresis. These
extracts exhibited the same allergen and protein profile, ruling out the possibility that
our results may depend on specific conditions of the year selected.
The allergenic potential in vivo of the different developmental stages of kiwi fruit
(September, October, November and December extracts) investigated by skin prick
tests was the highest in extract of fruit collected in November. The amount of Act c 1
(actinidin) was the highest in the same sample. The content of this major allergen of
kiwi fruit was measured by rocket immunoelectrophoresis, densitometry and
proteolytic activity. Proteolytic activity increased in September to November kiwi
fruit extracts and decreased in the December extract, while the actinidin contents
determined by densitometry and RIE for September, October and December samples
were comparable. These results led us to conclude that actinidin might not be fully
active in unripe kiwi fruit and that the amount and activity decreased with
overripening. According to our results, determination of proteolytic activity cannot
be an appropriate method for quantification of actinidin in different kiwi fruit samples.
Figure 5. Digestibility of kiwi fruit extracts in SGF.
Lane m, Molecular weight markers; S, September; O, October; N, November and D, December kiwi fruit
extract; k, extract control; 1, after 8 min of digestion; 2, after 30 min of digestion; Lane P, pepsin control.
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Moreover, the difference in the content of Act c 1 (measured by RIE and
densitometry) was not sufficiently pronounced to fully explain the extent of patients’
reactions. It seems likely that other allergens, whose content also changes during
development, contribute to the intensity of skin reactions. In the December extract the
intensity of a more basic isoform of Act c 2 on 2D PAGE was higher when compared
to the September, October and November extracts. Interestingly, it seems that this
isoform, with a presumably higher allergenic potential, appeared to be more prone to
digestion in simulated gastric conditions (see Figure 5). Additionally, we noticed that
the expression of some until now uncharacterized allergens, started in September and
intensified to reach the highest value in November and December (17, 22, 26, 39 and
67 kDa molecular weights). These allergens may also contribute to higher allergenicity
of the November extract. Also, it would be of interest to examine the role that these
proteins may play in the process of kiwi fruit development.
A previous study by Paschke et al. (2001) showed no difference between allergenic
potency of mango fruit during ripening but cannot be directly compared with our
results due to the different time-scale of food collection (different fruit developmental
stage samples). Kiwi fruits used in our study were harvested in September and
October as unripe, while November and December kiwi fruits were ripe and edible.
The fruit extracts were made immediately after harvesting. Paschke et al. (2001)
performed their experiments only on extracts of consumable and fully developed
mango fruit made five to 40 days after harvesting.
According to our results, one of the factors that contribute to the difficulties in
proposing well-defined and standardized fruit extracts should also be time (develop-
mental stage) of fruit harvesting. In this particular case, when the kiwi fruit was edible
throughout November and December, we clearly showed strong discrepancies in
allergen content and potencies both in qualitative and quantitative terms. It seems that
in the case of kiwi fruit, the fully ripened fruit contains less allergens and was able to
induce less pronounced allergic reaction in the SPT in the group of tested patients.
However, when considering the allergen extract preparation, it should be kept in mind
that not only the content of major allergens, but also the ratio of different proteins and
even isoforms of the same allergen change with fruit ripening and development. For an
optimized extract preparation, a well defined harvesting time should be taken into
account. For the improvement of in vitro allergy diagnosis preparations based on
optimized allergen extracts as well as recombinant allergens of natural fruit allergens
(Vieths et al. 2001) may be a promising solution for this very complex problem.
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